Literature DB >> 15980281

Macronutrients and bioactive molecules: is there a specific role in the management of inflammatory bowel disease?

Miquel A Gassull1, Josep Mañé, Elisabet Pedrosa, Eduard Cabre.   

Abstract

The effect of bioactive nutrient molecules on inflammatory response has an archetype in Inflammatory Bowel Disease. The exacerbated inflammatory response in such conditions can be nutritionally modified by 2 ways: changing the response of the host, or changing the composition of the intestinal ecosystem. Host response can be modified by changing the cell structure and function which is nutrient dependent. Nutrient deprivation will lead to a situation where there is not enough building material for cell replacement and the synthesis of mediators (enzymes, hormones, etc). However, this may occur even in a situation where there is no quantitative nutrient deprivation but only qualitative changes. In Inflammatory Bowel Disease, changes in the sources of some nutrients such as lipids or carbohydrates (CHO) can modify the inflammatory response. Lipids, by changing cell membrane composition, may modify the pattern of eicosanoid synthesis, intracellular signal transmission and activation of nuclear transcription factors, which modify the expression of some genes-that is, changing the host response. On the other hand, certain sources of carbohydrates, by undergoing anaerobic bacterial fermentation, drop the pH in the intestinal lumen favoring the growth of certain strains of bacteria which act favorably in maintaining tolerance in the bowel. In addition, as a consequence of CHO fermentation, short-chain fatty acids are produced which, especially butyrate, may act in 2 ways: by providing energy to the epithelial cells, but also as anti-inflammatory substrate-that is, modifying at least 1 of the mechanisms triggering the inflammatory response enhancement. However, it should not be forgotten that the cellular response to dietary modifications will depend on the individual genome, as has been recently observed. This may explain why some individuals do and others do not show a similar response to dietary interventions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15980281     DOI: 10.1177/01486071050290S4S179

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  4 in total

1.  Can nutritional therapy replace pharmacologic therapy in pediatric Crohn's disease?

Authors:  Miquel A Gassull
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-12-23

Review 2.  Impact of environmental and dietary factors on the course of inflammatory bowel disease.

Authors:  Eduard Cabré; Eugeni Domènech
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

3.  Differences in dietary habits between patients with inflammatory bowel disease in clinical remission and a healthy population.

Authors:  Mariabeatrice Principi; Giuseppe Losurdo; Andrea Iannone; Antonella Contaldo; Valentina Deflorio; Nunzio Ranaldo; Antonio Pisani; Enzo Ierardi; Alfredo Di Leo; Michele Barone
Journal:  Ann Gastroenterol       Date:  2018-05-07

Review 4.  Food and Food Groups in Inflammatory Bowel Disease (IBD): The Design of the Groningen Anti-Inflammatory Diet (GrAID).

Authors:  Marjo J E Campmans-Kuijpers; Gerard Dijkstra
Journal:  Nutrients       Date:  2021-03-25       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.